Preliminary results indicate that MYCN binds the p21 promoter, suggesting that in MYCN-amplified neuroblastoma MYCN exerts an additional suppressing activity on p21 expression at transcriptional level (data not shown). Here, MYCN is linked to neuroblastoma.